Fundies.
English

CymaBay Therapeutics, Inc.

EDGAR
CBAY Annual report (10-K) · filed 2024-02-28

179 filing records in this dataset, filed from 2013-11-25 to 2024-02-28. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

57 thousand USD

2023 Q4 · USD

Exact inputs and evidence

Operating margin

-74,557.89%

2023 Q4 · %

Exact inputs and evidence
  • Operating Income: -101679000 USD Source
  • Operating Income: -59181000 USD Source
  • Revenue: 31073000 USD Source
  • Revenue: 31016000 USD Source

Operating cash flow

-27.3 million USD

2023 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -72500000 USD Source
  • Operating Cash Flow: -45200000 USD Source

Free cash flow

-27.5 million USD

2023 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -72500000 USD Source
  • Operating Cash Flow: -45200000 USD Source
  • Capital Expenditure: 445000 USD Source
  • Capital Expenditure: 265000 USD Source
Cash and cash equivalents
207 million USD Source
Exact value

206535000 USD

Long-term debt including current maturities
Not available
Shares outstanding
114 million shares Source
Exact value

113864976 shares

Reported share-count change

34.46% · 29.2 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 84681063 shares · 2022-12-31· Source
  • 113864976 shares · 2023-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-105 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence
  • Net income: -28778000 USD · 2023-01-01 – 2023-03-31 Source
  • Net income: -808000 USD · 2023-04-01 – 2023-06-30 Source
  • Net income: -33882000 USD · 2023-07-01 – 2023-09-30 Source
  • Net income: -105370000 USD · 2023-01-01 – 2023-12-31 Source
  • Net income: -63468000 USD · 2023-01-01 – 2023-09-30 Source

Operating cash flow

-72.5 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence
  • Operating cash flow: 6400000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -19000000 USD · 2023-01-01 – 2023-06-30 Source
  • Operating cash flow: 6400000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -45200000 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -19000000 USD · 2023-01-01 – 2023-06-30 Source
  • Operating cash flow: -72500000 USD · 2023-01-01 – 2023-12-31 Source
  • Operating cash flow: -45200000 USD · 2023-01-01 – 2023-09-30 Source

Capital expenditure

445 thousand USD

2023-01-01 – 2023-12-31

Exact inputs and evidence
  • Capital expenditure: 195000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 265000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 195000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 265000 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 265000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 445000 USD · 2023-01-01 – 2023-12-31 Source
  • Capital expenditure: 265000 USD · 2023-01-01 – 2023-09-30 Source

Free cash flow

-72.9 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence
  • Operating cash flow: 6400000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -19000000 USD · 2023-01-01 – 2023-06-30 Source
  • Operating cash flow: 6400000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -45200000 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -19000000 USD · 2023-01-01 – 2023-06-30 Source
  • Operating cash flow: -72500000 USD · 2023-01-01 – 2023-12-31 Source
  • Operating cash flow: -45200000 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 195000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 265000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 195000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 265000 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 265000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 445000 USD · 2023-01-01 – 2023-12-31 Source
  • Capital expenditure: 265000 USD · 2023-01-01 – 2023-09-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-02-28.

Financial data available through: 2023-12-31.

Coverage by financial measure
  • Revenue: 4 of 11 periods available· newest 2023-12-31
  • Operating income: 11 of 11 periods available· newest 2023-12-31
  • Net income: 11 of 11 periods available· newest 2023-12-31
  • Operating cash flow: 11 of 11 periods available· newest 2023-12-31
  • Capital expenditure: 9 of 11 periods available· newest 2023-12-31
  • Total assets: 4 of 11 periods available· newest 2023-12-31
  • Total liabilities: 4 of 11 periods available· newest 2023-12-31
  • Current assets: 4 of 11 periods available· newest 2023-12-31
  • Current liabilities: 4 of 11 periods available· newest 2023-12-31
  • Cash and cash equivalents: 4 of 11 periods available· newest 2023-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 4 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +USD 31.07 million

    Prior period

    USD 0

    –

    Current period

    USD 31.07 million

    –

    Exact inputs and evidence

    31073000 − 0 = 31073000 USD

    0 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    31073000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 631,000

    Prior period

    −USD 106 million

    –

    Current period

    −USD 105.37 million

    –

    Exact inputs and evidence

    -105370000 − -106001000 = 631000 USD

    -106001000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -105370000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 11.58 million

    Prior period

    −USD 84.08 million

    –

    Current period

    −USD 72.5 million

    –

    Exact inputs and evidence

    -72500000 − -84080000 = 11580000 USD

    -84080000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -72500000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +200.7%

    Prior period

    USD 148,000

    –

    Current period

    USD 445,000

    –

    Exact inputs and evidence

    445000 − 148000 = 297000 USD

    148000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    445000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

  • Revenue USD 31.07 million 100% of revenue
  • Operating costs Derived USD 132.75 million 427% of revenue
  • Operating income −USD 101.68 million −327% of revenue
  • Tax, interest and other Derived USD 3.69 million 12% of revenue
  • Net income −USD 105.37 million −339% of revenue

Cash

  • Operating cash flow −USD 72.5 million −233% of revenue
  • Capital expenditure USD 445,000 1.4% of revenue
  • Free cash flow Derived −USD 72.95 million −235% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2017 Operating loss: operating costs were 313% of revenue.
  • 2021 Not shown: operating income or net income is not reported.
  • 2022 Not shown: operating income or net income is not reported.
  • 2023 Operating loss: operating costs were 427% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2017 2017-01-01 – 2017-12-3110000000 31325000 Derived -21325000 6232000 Derived -27557000 -19659000 Derived
Source
2021 2021-01-01 – 2021-12-310 87582000 Derived -87582000 2416000 Derived -89998000 -69518000 Derived
Source
2022 2022-01-01 – 2022-12-310 93111000 Derived -93111000 12890000 Derived -106001000 -84228000 Derived
Source
2023 2023-01-01 – 2023-12-3131073000 132752000 Derived -101679000 3691000 Derived -105370000 -72945000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 31.1M 2023
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.33.6M25.2M16.8M8.4M0.02017202120222023
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2017Revenue10000000
2021Revenue0
2022Revenue0
2023Revenue31073000

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2017Year over yearNo prior comparable period
2021Year over yearNo prior comparable period
2022Year over yearNo prior comparable period
2023Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -327.2% 2023
Net margin -339.1% 2023
Free cash flow margin -234.8% 2023
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.27%-71%-170%-268%-366%2017202120222023
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2017Operating margin-213.2%
2021Operating marginNot reported
2022Operating marginNot reported
2023Operating margin-327.2%
2017Net margin-275.6%
2021Net marginNot reported
2022Net marginNot reported
2023Net margin-339.1%
2017Free cash flow margin-196.6%
2021Free cash flow marginNot reported
2022Free cash flow marginNot reported
2023Free cash flow margin-234.8%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -72.5M 2023
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6.7M-17.7M-42.0M-66.4M-90.8M2017202120222023
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2017Operating cash flow-19632000
2021Operating cash flow-69431000
2022Operating cash flow-84080000
2023Operating cash flow-72500000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -72.9M 2023
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6.7M-17.7M-42.1M-66.5M-91.0M2017202120222023
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2017Free cash flow-19659000
2021Free cash flow-69518000
2022Free cash flow-84228000
2023Free cash flow-72945000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

32.8% 2023
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.80%60%40%20%0%2017202120222023
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2017Liabilities / assets18.5%
2021Liabilities / assets34.3%
2022Liabilities / assets74.5%
2023Liabilities / assets32.8%

Current assets to current liabilities

Current assets divided by current liabilities.

10.96× 2023
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.11.84×8.88×5.92×2.96×0.00×2017202120222023
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2017Current assets / current liabilities6.35×
2021Current assets / current liabilities10.41×
2022Current assets / current liabilities8.94×
2023Current assets / current liabilities10.96×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2014 2014-01-01 – 2014-12-31
−USD 31.92 million
Exact value

Exact value: -31917000 USD

2014-01-01 – 2014-12-31: -31917000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.11 million
Exact value

Exact value: -21114000 USD

2014-01-01 – 2014-12-31: -21114000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 103,000
Exact value

Exact value: 103000 USD

2014-01-01 – 2014-12-31: 103000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.22 million
Calculation and evidence

-21114000 − 103000 USD

Exact free cash flow: -21217000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2015 2015-01-01 – 2015-12-31
−USD 15.53 million
Exact value

Exact value: -15529000 USD

2015-01-01 – 2015-12-31: -15529000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 23.32 million
Exact value

Exact value: -23324000 USD

2015-01-01 – 2015-12-31: -23324000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2016 2016-01-01 – 2016-12-31
−USD 26.67 million
Exact value

Exact value: -26671000 USD

2016-01-01 – 2016-12-31: -26671000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 23.35 million
Exact value

Exact value: -23353000 USD

2016-01-01 – 2016-12-31: -23353000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 42,000
Exact value

Exact value: 42000 USD

2016-01-01 – 2016-12-31: 42000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 23.4 million
Calculation and evidence

-23353000 − 42000 USD

Exact free cash flow: -23395000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2017-01-01 – 2017-12-31
−USD 27.56 million
Exact value

Exact value: -27557000 USD

2017-01-01 – 2017-12-31: -27557000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 19.63 million
Exact value

Exact value: -19632000 USD

2017-01-01 – 2017-12-31: -19632000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 27,000
Exact value

Exact value: 27000 USD

2017-01-01 – 2017-12-31: 27000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 19.66 million
Calculation and evidence

-19632000 − 27000 USD

Exact free cash flow: -19659000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
−USD 72.55 million
Exact value

Exact value: -72548000 USD

2018-01-01 – 2018-12-31: -72548000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 54.94 million
Exact value

Exact value: -54936000 USD

2018-01-01 – 2018-12-31: -54936000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 529,000
Exact value

Exact value: 529000 USD

2018-01-01 – 2018-12-31: 529000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 55.47 million
Calculation and evidence

-54936000 − 529000 USD

Exact free cash flow: -55465000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 102.81 million
Exact value

Exact value: -102808000 USD

2019-01-01 – 2019-12-31: -102808000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 97.91 million
Exact value

Exact value: -97911000 USD

2019-01-01 – 2019-12-31: -97911000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 315,000
Exact value

Exact value: 315000 USD

2019-01-01 – 2019-12-31: 315000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 98.23 million
Calculation and evidence

-97911000 − 315000 USD

Exact free cash flow: -98226000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 50.99 million
Exact value

Exact value: -50986000 USD

2020-01-01 – 2020-12-31: -50986000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 44.73 million
Exact value

Exact value: -44725000 USD

2020-01-01 – 2020-12-31: -44725000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 21,000
Exact value

Exact value: 21000 USD

2020-01-01 – 2020-12-31: 21000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 44.75 million
Calculation and evidence

-44725000 − 21000 USD

Exact free cash flow: -44746000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 90 million
Exact value

Exact value: -89998000 USD

2021-01-01 – 2021-12-31: -89998000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 69.43 million
Exact value

Exact value: -69431000 USD

2021-01-01 – 2021-12-31: -69431000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 87,000
Exact value

Exact value: 87000 USD

2021-01-01 – 2021-12-31: 87000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 69.52 million
Calculation and evidence

-69431000 − 87000 USD

Exact free cash flow: -69518000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 106 million
Exact value

Exact value: -106001000 USD

2022-01-01 – 2022-12-31: -106001000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 84.08 million
Exact value

Exact value: -84080000 USD

2022-01-01 – 2022-12-31: -84080000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 148,000
Exact value

Exact value: 148000 USD

2022-01-01 – 2022-12-31: 148000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 84.23 million
Calculation and evidence

-84080000 − 148000 USD

Exact free cash flow: -84228000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 105.37 million
Exact value

Exact value: -105370000 USD

2023-01-01 – 2023-12-31: -105370000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 72.5 million
Exact value

Exact value: -72500000 USD

2023-01-01 – 2023-12-31: -72500000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 445,000
Exact value

Exact value: 445000 USD

2023-01-01 – 2023-12-31: 445000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 72.95 million
Calculation and evidence

-72500000 − 445000 USD

Exact free cash flow: -72945000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

179 filings · 2,721 latest values · 2,721 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001042074, 1042074, CBAY, CYMA, edgar:1042074

Also known as CYMABAY THERAPEUTICS, INC., CymaBay Therapeutics, Inc., METABOLEX INC, METABOLEX, INC.